Wuhan First Biotechnology Co., Ltd. announced a private placement of common share for the gross proceeds of CNY 80 million on March 23, 2021. The transaction will include participation from existing investors Ningbo Tianlong Electronics Co., Ltd., Ningbo Meishan Free Trade Port Zone Ruisu Equity Investment Partnership (Limited Partnership), Guangdong Baochuang Win-Win Science and Technology Equity Investment Partnership (Limited Partnership), Hangzhou Fengwo Enterprise Management Partnership (Limited Partnership), Qingdao Tianchuang Quanxin Venture Capital Partnership (Limited Partnership) and Shanghai Qiangdong Enterprise Management Partnership (Limited Partnership). Post completion of transaction, Ningbo Tianlong Electronics Co., Ltd. will hold 3.5714% of the company and registered capital of the company will increase from CNY 2.727413 million to CNY 2.969850 million. The transaction has been approved at the 22nd meeting of the third board of directors.